Use of anti-CD83 agonist antibodies for treating autoimmune diseases
US9562097B2 · kind B2 · utility
0Cited by
38References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2012 |
| Grant date | Feb 7, 2017 |
| Priority date | — |
| Expiry date | Jul 2, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compositions comprising anti-CD83 agonist antibodies and methods of treating autoimmune disorders (such as inflammatory bowel disease) with anti-CD83 agonist antibodies, as well as articles of manufacture comprising anti-CD83 agonist antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.